Neil J Fernandes

SVP Neil J Fernandes sold 7,659 shares of LRCX at $309.60 (total $2.4M); post-sale holdings 58.5K shares under 10b5-1 plan.

Neil J Fernandes executed a scheduled sale of 7,659 shares under a 10b5-1 trading plan adopted on 2025-11-17, reducing his LRCX holdings by -11.6% to 58.5K shares. The stock traded at $309.60 on 2026-06-01 and currently sits at $332.22, near its 52-week high of $333.33. His prior LRCX sales on 2026-05-01 and 2024-07-12 show divergent outcomes: the May 2026 sale saw subsequent price appreciation (+24.7% in 30 days), while the July 2024 and June 2024 sales preceded sharp declines of -92.4% and -91.5% respectively. As a pre-arranged transaction, the timing reflects the plan's schedule rather than discretionary market judgment.

SVP Neil Fernandes sells ~$4.6M in LAM shares, trimming position by over one-fifth at elevated valuation.

Neil Fernandes, a Senior Vice President at LAM Research, sold roughly one-fifth of his shareholdings in a single transaction, raising approximately $4.6 million. The sale occurred when the stock was trading near the middle of its recent range—down slightly from all-time highs but still benefiting from strong momentum over recent months. As a C-suite officer with direct operational insight into the company, his decision to trim a substantial block of shares warrants attention, particularly given that the company's financial position remains strong with healthy profitability and growing revenue. However, the sale is not dramatic enough to suggest panic; rather, it appears consistent with a disciplined officer rebalancing a concentrated position or taking gains after a period of appreciation. The timing and size merit observation, though this is not uncommon for senior executives managing their personal wealth after periods of strong stock performance.

SVP Fernandes Neil J sold 1,620 shares ($1.7M) of LRCX at $1,056.99 on 2024-07-12; post-transaction holdings 5,237 shares.

Neil J Fernandes, Senior Vice President, sold 1,620 shares of LAM RESEARCH CORP (LRCX) for $1,712,323.80 on 2024-07-12, reducing his holdings by 23.6% from 6,857 to 5,237 shares. His cross-ticker track record shows 2 prior sells with a 100.00% well-timed rate at the 90-day mark (average 90d return -89.5%), though at LRCX specifically, only 1 prior sell is measurable with a -89.5% 90d return. The current stock price of $106.91 is -5.2% from the 52-week high of $112.73, and the company trades at a P/E of 3.21 with solid fundamentals including $3.8B revenue and $965.8M net income. The sale represents material liquidation of an insider's position over a short period (two LRCX sells within 15 days), warranting investor attention to whether this signals forward-looking concerns or simply portfolio rebalancing unrelated to company-specific outlook.

SVP Fernandes sells 4,409 LRCX shares (39.1% of holdings) for $4.7M at $1,055.76; stock now at $106.06

Fernandes, Senior Vice President at Lam Research, executed a substantial open-market sale reducing his holdings from 11,266 to 6,857 shares—a 39.1% reduction—on 2024-06-27 at $1,055.76 per share, generating $4,654,845.84 in proceeds. The transaction price ($1,055.76) substantially exceeded the current price ($106.06), representing a price collapse of approximately 90% since the sale date. His cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100.00%, and his single prior sale at LRCX on 2024-02-01 exhibited negative 90-day returns (-89.5%), indicating the stock declined after that insider sale as well. This second sale at the same ticker, executed months later at a dramatically higher price point, repeats the pattern: a major reduction in personal holdings followed by subsequent stock decline, though the magnitude of this price movement is exceptional.